We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

77 hedge funds and large institutions have $648M invested in BELLUS Health Inc. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 13

55% more call options, than puts

Call options by funds: $2.57M | Put options by funds: $1.66M

9% less capital invested

Capital invested by funds: $711M → $648M (-$62.7M)

13% less funds holding

Funds holding: 8977 (-12)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

46% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 24

Holders
77
Holders Change
-12
Holders Change %
-13.48%
% of All Funds
1.21%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
13
Increased
31
Reduced
13
Closed
24
Calls
$2.57M
Puts
$1.66M
Net Calls
+$912K
Net Calls Change
+$4.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
26
BlackRock
New York
$5.51M +$1.55M +241,327 +43%
SAM
27
Sectoral Asset Management
Quebec, Canada
$5.44M +$442K +68,671 +10%
Millennium Management
28
Millennium Management
New York
$5.21M -$19.9M -3,083,130 -80%
TCM
29
Tang Capital Management
California
$4.13M -$3.86M -600,000 -50%
AAA
30
Affinity Asset Advisors
New York
$4.13M +$644K +100,000 +20%
ECM
31
ExodusPoint Capital Management
New York
$3.14M +$2.29M +355,227 +352%
PVI
32
Pura Vida Investments
New York
$2.68M +$14.8K +2,300 +0.6%
AIC
33
AWM Investment Company
New York
$2.61M
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$2.39M +$2.24M +347,247 New
Barclays
35
Barclays
United Kingdom
$2.07M +$1.94M +300,815 New
Morgan Stanley
36
Morgan Stanley
New York
$2.03M +$1.52M +235,902 +395%
SSA
37
Schonfeld Strategic Advisors
New York
$1.53M -$607K -94,192 -30%
Renaissance Technologies
38
Renaissance Technologies
New York
$1.44M +$1.15M +179,011 +625%
Adage Capital Partners
39
Adage Capital Partners
Massachusetts
$1.03M
JGC
40
J. Goldman & Co
New York
$787K -$550K -85,356 -43%
BFM
41
Boothbay Fund Management
New York
$764K +$716K +111,096 New
AA
42
ALPS Advisors
Colorado
$755K +$120K +18,615 +20%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$670K +$627K +97,334 New
Bank of America
44
Bank of America
North Carolina
$622K +$426K +66,179 +275%
FWSM
45
First Wilshire Securities Management
California
$564K
CSS
46
Cubist Systematic Strategies
Connecticut
$493K -$326K -50,662 -41%
HS
47
HighVista Strategies
Massachusetts
$448K +$420K +65,174 New
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$425K -$85.5K -13,270 -18%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$411K -$860K -133,486 -69%
Geode Capital Management
50
Geode Capital Management
Massachusetts
$390K

BLU Hedge Fund Activity: Q1 2022 in Review

77 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q1 2022, worth a combined $648M — down 8.8% from $711M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of BLU and 13 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 31 added.

The largest buyer was Goldman Sachs, adding an estimated $39.8M. The largest seller was RTW Investments, exiting entirely with an estimated $48M sold.

  • 77 institutional investors held BELLUS Health Inc. (BLU) as of Q1 2022, down from 89 in Q4 2021.
  • Funds reported $648M of BELLUS Health Inc. stock for Q1 2022, down 8.8% quarter-over-quarter.
  • 13 funds opened new BELLUS Health Inc. positions in Q1 2022 and 24 closed out, a net change of -11 holders.
  • The largest BELLUS Health Inc. buyer in Q1 2022 was Goldman Sachs, an estimated $39.8M added.
  • The largest BELLUS Health Inc. seller in Q1 2022 was RTW Investments, an estimated $48M sold.

Based on aggregated 13F filings for Q1 2022.